← Open Payments lookup

ERIC FRORENZA-HUBBARD: Open Payments

NPI 1669012357 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,279 in 54 payments from 15 companies in 2025. Trend: 2023 $412 · 2024 $967 · 2025 $1,279

Food & beverage: $1,279
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.20$438
Novartis Pharmaceuticals Corporation8$175
Biosense Webster, Inc.3$158
PFIZER INC.5$99
Novo Nordisk Inc3$72
Amgen Inc.3$67
Boehringer Ingelheim Pharmaceuticals, Inc.2$48
Esperion Therapeutics, Inc.2$44
CVRx, Inc.2$37
Actelion Pharmaceuticals US, Inc.1$29

Products named: Kerendia, LEQVIO, CARTO 3, Wegovy, REPATHA, VYNDAQEL, JARDIANCE, NEXLETOL.

Industry payments across NV — which companies pay providers there.